Loading...

Elite Pharmaceuticals, Inc.

ELTP•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.55
$-0.01(-1.33%)

Elite Pharmaceuticals, Inc. (ELTP) Stock Overview

Explore Elite Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.4/100

Key Financials

Market Cap588.9M
P/E Ratio-53.84
EPS (TTM)$-0.01
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 Week$0.60
1 Month$0.57
3 Months$0.70
1 Year Target$1.23

ELTP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Elite Pharmaceuticals, Inc. (ELTP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -53.84 and a market capitalization of 588.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.47%
5-Day Change
14.44%
1-Month Change
-14.88%
3-Month Change
-17.58%
6-Month Change
1.38%
Year-to-Date (YTD) Change
-25.04%
1-Year Change
192.82%
3-Year Change
930.00%
5-Year Change
357.78%
All-Time (Max) Change
-96.92%

Contact Information

https://www.elitepharma.com
201 750 2646
165 Ludlow Avenue, Northvale, NJ, 07647

Company Facts

64 Employees
IPO DateFeb 24, 2000
CountryUS
Actively Trading

Frequently Asked Questions

;